Proto Labs, Inc. — Form 10-Q Summary
Period: Quarter ended March 31, 2012; comparisons are to the quarter ended March 31, 2011 unless otherwise noted. Proto Labs manufactures quick-turn custom parts through Protomold injection molding and Firstcut CNC machining, serving prototype and short-run production customers.
Financial performance
| Metric | Q1 2012 | Q1 2011 | Change |
|---|---|---|---|
| Revenue | $30.0 million | $22.3 million | +34.2% |
| Gross profit / margin | $17.7 million / 59.1% | $13.9 million / 62.3% | Profit +27.5%; margin down 3.2 percentage points |
| Operating income / margin | $7.6 million / 25.5% | $7.1 million / 31.7% | Income +8.0%; margin down 6.2 points |
| Net income | $4.8 million | $4.7 million | +1.2% |
| Net income per diluted share | $0.22 | $0.19 | Up; preferred-stock conversion affects comparability |
| Operating cash flow | $7.4 million | $6.0 million | +$1.4 million |
| Capital expenditures | $8.3 million | $2.3 million | +$6.0 million |
Cash was $79.7 million at March 31, 2012, versus $8.1 million at year-end 2011, primarily reflecting $71.6 million of net IPO proceeds. Total debt obligations were $0.9 million, including $0.4 million current, versus $1.0 million at December 31. Total current assets were $102.7 million and current liabilities $13.7 million. No off-balance-sheet arrangements were reported.
Material changes and drivers
- Revenue growth reflected increased marketing and sales activity, higher customer counts, and growth across products and geographies. Existing customers contributed approximately $4.7 million of the increase and new customers approximately $2.9 million. No single customer represented more than approximately 1% of revenue.
- Firstcut revenue rose 51.0% to $8.2 million; Protomold rose 28.8% to $21.8 million. International revenue increased 59.0% to $7.8 million and represented 26% of total revenue.
- Cost of revenue grew 45.2%, faster than revenue. Management attributed this to higher materials and production costs, facility and equipment costs, and direct labor. Lower equipment utilization following capacity additions also pressured gross margin.
- Operating expenses increased 47.7% to $10.1 million, including higher marketing, R&D, staffing, public-company costs, and stock-based compensation. Stock-based compensation was $0.9 million versus $0.2 million.
- Other expense increased to $0.6 million from $0.1 million, primarily due to foreign-currency movements. The effective tax rate was 32.3%, compared with 32.5%.
Outlook, risks and unusual items
- No numerical revenue or earnings guidance is provided. Management expects cost of revenue to increase in dollars but remain relatively constant as a share of revenue, and anticipates continued investment in personnel, technology, marketing, and R&D. It also expects G&A to rise as the company builds public-company infrastructure.
- The February 2012 IPO raised approximately $71.6 million net. Preferred and redeemable common shares converted into common stock; the IPO also ended certain investor put and management rights. The company intends to use proceeds for working capital and general corporate purposes, with possible investment in complementary businesses or additional capacity.
- International revenue was adversely affected by approximately $0.5 million from U.S. dollar strengthening. The company does not hedge foreign-exchange exposure; it stated that a hypothetical 10% adverse currency move would not materially affect results.
- Unrecognized tax benefits were $0.4 million; management did not anticipate a material change over the next 12 months. The company reported no litigation expected to have a material adverse effect and no material changes to previously disclosed risk factors.
- Management concluded disclosure controls were effective and reported no material changes in internal control over financial reporting. Proto Labs identified itself as an emerging growth company and elected private-company effective dates for new accounting standards.
Important facts for investors to verify
- Whether revenue growth can continue while gross and operating margins recover from the quarter’s declines, particularly as new capacity is utilized.
- How elevated capital spending translates into production capacity, utilization, and future cash generation.
- The persistence and causes of higher operating expenses, including stock compensation and public-company costs.
- International growth, foreign-exchange exposure, and the company’s decision not to hedge currency risk.
- The filing’s cover page marks “No” for having filed all required Exchange Act reports during the preceding 12 months; verify the context and any implications.